Sequenom Inc (SQNM)

2.39
0.01 0.42
NASDAQ : Health Care
Prev Close 2.40
Open 2.39
Day Low/High 2.39 / 2.40
52 Wk Low/High 0.00 / 0.00
Volume 2.05M
Avg Volume 2.19M
Exchange NASDAQ
Shares Outstanding 119.24M
Market Cap 284.99M
EPS -0.10
P/E Ratio N/A
Div & Yield N.A. (N.A)
Sequenom's Management Presents At Bank Of America Merrill Lynch 2012 Healthcare Conference (Transcript)

Sequenom's Management Presents At Bank Of America Merrill Lynch 2012 Healthcare Conference (Transcript)

Sequenom's Management Presents at Bank of America Merrill Lynch 2012 Healthcare Conference (Transcript)

Sequenom Inc. (SQNM): Today's Featured Drugs Winner

Sequenom Inc. (SQNM): Today's Featured Drugs Winner

Sequenom was a winner within the drugs industry, rising 12 cents (2.3%) to $5.40 on heavy volume.

Sequenom's CEO Discusses Q1 2012 Results - Earnings Call Transcript

Sequenom's CEO Discusses Q1 2012 Results - Earnings Call Transcript

Sequenom's CEO Discusses Q1 2012 Results - Earnings Call Transcript

8 Stocks Under $10 Making Big Moves

8 Stocks Under $10 Making Big Moves

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Sequenom Stock Hits New 52-Week Low (SQNM)

Sequenom Stock Hits New 52-Week Low (SQNM)

Sequenom (Nasdaq:SQNM) hit a new 52-week low Tuesday as it is currently trading at $3.55, below its previous 52-week low of $3.57 with 2.7 million shares traded as of 2:15 p.m. ET. Average volume has been 2.5 million shares over the past 30 days.

Sequenom's Management Presents At Barclays Capital 2012 Global Healthcare Conference (Transcript)

Sequenom's Management Presents At Barclays Capital 2012 Global Healthcare Conference (Transcript)

Sequenom's Management Presents at Barclays Capital 2012 Global Healthcare Conference (Transcript)

Sequenom's CEO Discusses Q4 2011 Results - Earnings Call Transcript

Sequenom's CEO Discusses Q4 2011 Results - Earnings Call Transcript

Sequenom's CEO Discusses Q4 2011 Results - Earnings Call Transcript

Sequenom CEO Presents At 30th Annual J.P. Morgan Healthcare Conference (Transcript)

Sequenom CEO Presents At 30th Annual J.P. Morgan Healthcare Conference (Transcript)

Sequenom CEO Presents at 30th Annual J.P. Morgan Healthcare Conference (Transcript)

Sequenom Stock Falls On Unusually High Volume (SQNM)

Sequenom Stock Falls On Unusually High Volume (SQNM)

Sequenom (Nasdaq:SQNM) is trading at unusually high volume Friday with 9.8 million shares changing hands. It is currently at four times its average daily volume and trading down 26 cents (-5.6%).

Sequenom Stock Hits New 52-Week Low (SQNM)

Sequenom Stock Hits New 52-Week Low (SQNM)

Sequenom (Nasdaq:SQNM) hit a new 52-week low Wednesday as it is currently trading at $3.81, below its previous 52-week low of $3.82 with 1.8 million shares traded as of 2:35 p.m. ET. Average volume has been 2.4 million shares over the past 30 days.

Sequenom's CEO Presents At Lazard Capital Markets 8th Annual Healthcare Conference - Conference Call Transcript

Sequenom's CEO Presents At Lazard Capital Markets 8th Annual Healthcare Conference - Conference Call Transcript

Sequenom's CEO Presents at Lazard Capital Markets 8th Annual Healthcare Conference - Conference Call Transcript

5 Stocks With Big Insider Buying

5 Stocks With Big Insider Buying

Insiders at these companies have been scooping up shares of their own stock.

Sequenom Stock Hits New 52-Week Low (SQNM)

Sequenom Stock Hits New 52-Week Low (SQNM)

Sequenom (Nasdaq:SQNM) hit a new 52-week low Monday as it is currently trading at $3.98, below its previous 52-week low of $4 with 2.3 million shares traded as of 2 p.m. ET. Average volume has been 2.2 million shares over the past 30 days.

Sequenom CEO Hosts 2011 Analyst And Investor Day

Sequenom CEO Hosts 2011 Analyst And Investor Day

Sequenom CEO Hosts 2011 Analyst and Investor Day

Sequenom Stock Hits New 52-Week Low (SQNM)

Sequenom Stock Hits New 52-Week Low (SQNM)

Sequenom (Nasdaq:SQNM) hit a new 52-week low Thursday as it is currently trading at $4.08, below its previous 52-week low of $4.10 with 1.7 million shares traded as of 3:10 p.m. ET. Average volume has been 2.1 million shares over the past 30 days.

Sequenom CEO Discusses Q3 2011 Results - Earnings Call Transcript

Sequenom CEO Discusses Q3 2011 Results - Earnings Call Transcript

Sequenom CEO Discusses Q3 2011 Results - Earnings Call Transcript

Sequenom Stock Hits New 52-Week Low (SQNM)

Sequenom Stock Hits New 52-Week Low (SQNM)

Sequenom (Nasdaq:SQNM) hit a new 52-week low Wednesday as it is currently trading at $4.39, below its previous 52-week low of $4.40 with 1.5 million shares traded as of 1:10 p.m. ET. Average volume has been two million shares over the past 30 days.

Sequenom's CEO Hosts Launch Of MaterniT21 - Conference Call Transcript

Sequenom's CEO Hosts Launch Of MaterniT21 - Conference Call Transcript

Sequenom's CEO Hosts Launch of MaterniT21 - Conference Call Transcript

Sequenom Stock Hits New 52-Week Low (SQNM)

Sequenom Stock Hits New 52-Week Low (SQNM)

Sequenom (Nasdaq:SQNM) hit a new 52-week low Thursday as it is currently trading at $4.55, below its previous 52-week low of $4.57 with 909,616 shares traded as of 11:06 a.m. ET. Average volume has been 1.8 million shares over the past 30 days.

Sequenom Stock Falls On Unusually High Volume (SQNM)

Sequenom Stock Falls On Unusually High Volume (SQNM)

Sequenom (Nasdaq:SQNM) is trading at unusually high volume Tuesday with 6.1 million shares changing hands. It is currently at four times its average daily volume and trading down 63 cents (-11.3%).

7 Stocks Rising on Unusual Volume

7 Stocks Rising on Unusual Volume

Major moves in volume can signal unusual activity in stocks; here are seven stocks rising on unusual volume today.

10 Most Shorted Stocks in Biotech

10 Most Shorted Stocks in Biotech

Short-sellers are taking aim at Savient, Avanir Pharma and other biotech firms launching new drugs in a challenging economy.

Sequenom Stock Hits New 52-Week Low (SQNM)

Sequenom Stock Hits New 52-Week Low (SQNM)

Sequenom (Nasdaq:SQNM) hit a new 52-week low Thursday as it is currently trading at $5.06, below its previous 52-week low of $5.07 with 183,141 shares traded as of 11:16 a.m. ET. Average volume has been 1.5 million shares over the past 30 days.

Biotech Stock Mailbag: Idenix Pharma

Biotech Stock Mailbag: Idenix Pharma

Biotech columnist Adam Feuerstein answers readers' questions and concerns about health care and drug-related stocks.

11 Biotech Stocks Loved or Hated by Hedge Funds

11 Biotech Stocks Loved or Hated by Hedge Funds

A list of biotech stocks that saw signficant buying and selling from hedge funds in the second quarter.

Good Biotech Stocks for a Bear Market

Good Biotech Stocks for a Bear Market

Biotech stocks that can help investors weather the S&P downgrade of American's credit rating and the ensuing market sell off.

Sequenom Stock Hits New 52-Week Low (SQNM)

Sequenom Stock Hits New 52-Week Low (SQNM)

Sequenom (Nasdaq:SQNM) hit a new 52-week low Monday as it is currently trading at $5.42, below its previous 52-week low of $5.47 with 1.3 million shares traded as of 10:26 a.m. ET. Average volume has been 1.9 million shares over the past 30 days.

Sequenom's CEO Discusses Q2 2011 Results - Earnings Call Transcript

Sequenom's CEO Discusses Q2 2011 Results - Earnings Call Transcript

Sequenom's CEO Discusses Q2 2011 Results - Earnings Call Transcript

8 Stocks That Could Surge on Earnings

8 Stocks That Could Surge on Earnings

These heavily shorted stocks could get squeezed higher if they report positive earnings this week.

Sequenom's CEO Discusses Q1 2011 Results - Earnings Call Transcript

Sequenom's CEO Discusses Q1 2011 Results - Earnings Call Transcript

Sequenom's CEO Discusses Q1 2011 Results - Earnings Call Transcript